Enigma Diagnostics Raises $50M in Funding

Enigma Diagnostics, a Porton Down, Salisbury, UK-based provider of molecular diagnostic point-of-care infectious disease testing, raised $50m in funding.

Chinese private equity fund Shanghai Debay Capital made the investment.

The funding will be deployed over 18 months to support global commercialization of the Enigma® ML system following its CE marking in early 2014.

Led by John McKinley, Chairman, Enigma Diagnostics is a global leader in Point-of-Care infectious disease testing. Leveraging its proprietary technologies and Intellectual Property, the company has developed the Enigma® Mini Laboratory (ML) system, combining real-time PCR (polymerase chain reaction) with both laboratory and decentralised Point-of-Care testing for a wide range of DNA and RNA disease targets.

FinSMEs

22/10/2014

Join the discussion